These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19946604)

  • 1. High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.
    Braun K; Ehemann V; Wiessler M; Pipkorn R; Didinger B; Mueller G; Waldeck W
    Int J Med Sci; 2009 Nov; 6(6):338-47. PubMed ID: 19946604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMZ-BioShuttle--a reformulated temozolomide.
    Waldeck W; Wiessler M; Ehemann V; Pipkorn R; Spring H; Debus J; Didinger B; Mueller G; Langowski J; Braun K
    Int J Med Sci; 2008 Sep; 5(5):273-84. PubMed ID: 18797509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse-electron-demand Diels-Alder reaction as a highly efficient chemoselective ligation procedure: synthesis and function of a BioShuttle for temozolomide transport into prostate cancer cells.
    Pipkorn R; Waldeck W; Didinger B; Koch M; Mueller G; Wiessler M; Braun K
    J Pept Sci; 2009 Mar; 15(3):235-41. PubMed ID: 19177421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.
    Braun K; Wiessler M; Pipkorn R; Ehemann V; Bäuerle T; Fleischhacker H; Müller G; Lorenz P; Waldeck W
    Int J Med Sci; 2010 Sep; 7(6):326-39. PubMed ID: 20922134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors.
    Palma JP; Wang YC; Rodriguez LE; Montgomery D; Ellis PA; Bukofzer G; Niquette A; Liu X; Shi Y; Lasko L; Zhu GD; Penning TD; Giranda VL; Rosenberg SH; Frost DJ; Donawho CK
    Clin Cancer Res; 2009 Dec; 15(23):7277-90. PubMed ID: 19934293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rechallenge with temozolomide in patients with recurrent gliomas.
    Wick A; Pascher C; Wick W; Jauch T; Weller M; Bogdahn U; Hau P
    J Neurol; 2009 May; 256(5):734-41. PubMed ID: 19240962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
    Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.
    Braun K; Wiessler M; Ehemann V; Pipkorn R; Spring H; Debus J; Didinger B; Koch M; Muller G; Waldeck W
    Drug Des Devel Ther; 2009 Feb; 2():289-301. PubMed ID: 19920915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells.
    Happold C; Roth P; Wick W; Schmidt N; Florea AM; Silginer M; Reifenberger G; Weller M
    J Neurochem; 2012 Jul; 122(2):444-55. PubMed ID: 22564186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent.
    Chalmers AJ; Ruff EM; Martindale C; Lovegrove N; Short SC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1511-9. PubMed ID: 19931733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors.
    Bodell WJ; Gaikwad NW; Miller D; Berger MS
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):545-51. PubMed ID: 12815001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.
    Blough MD; Beauchamp DC; Westgate MR; Kelly JJ; Cairncross JG
    J Neurooncol; 2011 Mar; 102(1):1-7. PubMed ID: 20593219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular cholesterol level regulates sensitivity of glioblastoma cells against temozolomide-induced cell death by modulation of caspase-8 activation via death receptor 5-accumulation and activation in the plasma membrane lipid raft.
    Yamamoto Y; Tomiyama A; Sasaki N; Yamaguchi H; Shirakihara T; Nakashima K; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Sakai R; Namba H; Mori K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1292-1299. PubMed ID: 29162448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells.
    Yan Y; Wang Y; Zhao P; Ma W; Hu Z; Zhang K
    Reprod Sci; 2017 Dec; 24(12):1620-1629. PubMed ID: 28270035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo.
    Chen TC; Cho HY; Wang W; Barath M; Sharma N; Hofman FM; Schönthal AH
    Mol Cancer Ther; 2014 May; 13(5):1181-93. PubMed ID: 24623736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells.
    Bektas M; Johnson SP; Poe WE; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1053-8. PubMed ID: 19597728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.